Erik Braziulis
Boston Children's Hospital
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Erik Braziulis.
Journal of Investigative Dermatology | 2009
Luca Pontiggia; Thomas Biedermann; Martin Meuli; Daniel S. Widmer; Sophie Böttcher-Haberzeth; Clemens Schiestl; Jörg Schneider; Erik Braziulis; Irene Montaño; Claudia Meuli-Simmen; Ernst Reichmann
We screened a series of antibodies for their exclusive binding to the human hair follicle bulge. In a second step these antibodies were to be used to identify basal keratinocytes and potential epithelial stem cells in the human epidermis and in engineered skin substitutes. Of all the antibodies screened, we identified only one, designated C8/144B, that exclusively recognized the hair follicle bulge. However, C8/144B-binding cells were never detected in the human epidermal stratum basale. In the bulge C8/144B-binding cells gave rise to cytokeratin 19-positive cells, which were also tracked in the outer root sheath between bulge and the hair follicle matrix. Remarkably, cytokeratin 19-expressing cells were never detected in the hair follicle infundibulum. Yet, cytokeratin 19-expressing keratinocytes were found in the epidermal stratum basale of normal skin as a subpopulation of cytokeratin 15-positive (not C8/144B-positive) basal keratinocytes. Cytokeratin 19/cytokeratin 15-positive keratinocytes decreased significantly with age. We suggest that cytokeratin 19-expressing cells represent a subpopulation of basal keratinocytes in neonates and young children (up to 1.5 years) that is particularly adapted to the lateral expansion of growing skin. Our data show that cytokeratin 19 in combination with cytokeratin 15 is an important marker to routinely monitor epidermal homeostasis and (at least indirectly) the self-renewing potential of engineered skin.
Journal of Investigative Dermatology | 2013
Sophie Böttcher-Haberzeth; Thomas Biedermann; Luca Pontiggia; Erik Braziulis; Clemens Schiestl; Bart Hendriks; Ossia M. Eichhoff; Daniel S. Widmer; Claudia Meuli-Simmen; Martin Meuli; Ernst Reichmann
Recently, Biedermann et al. (2010) have demonstrated that human eccrine sweat gland cells can develop a multilayered epidermis. The question still remains whether these cells can fulfill exclusive and very specific functional properties of epidermal keratinocytes, such as the incorporation of melanin, a feature absent in sweat gland cells. We added human melanocytes to eccrine sweat gland cells to let them develop into an epidermal analog in vivo. The interaction between melanocytes and sweat gland-derived keratinocytes was investigated. The following results were gained: (1) macroscopically, a pigmentation of the substitutes was seen 2-3 weeks after transplantation; (2) we confirmed the development of a multilayered, stratified epidermis with melanocytes distributed evenly throughout the basal layer; (3) melanocytic dendrites projected to suprabasal layers; and (4) melanin was observed to be integrated into former eccrine sweat gland cells. These skin substitutes were similar or equal to skin substitutes cultured from human epidermal keratinocytes. The only differences observed were a delay in pigmentation and less melanin uptake. These data suggest that eccrine sweat gland cells can form a functional epidermal melanin unit, thereby providing striking evidence that they can assume one of the most characteristic keratinocyte properties.
Journal of Tissue Engineering and Regenerative Medicine | 2016
Fabienne Hartmann-Fritsch; Thomas Biedermann; Erik Braziulis; Joachim Luginbühl; Luca Pontiggia; Sophie Böttcher-Haberzeth; Toin H. van Kuppevelt; Kaeuis A. Faraj; Clemens Schiestl; Martin Meuli; Ernst Reichmann
Extensive full‐thickness skin loss, associated with deep burns or other traumata, represents a major clinical problem that is far from being solved. A promising approach to treat large skin defects is the use of tissue‐engineered full‐thickness skin analogues with nearly normal anatomy and function. In addition to excellent biological properties, such skin substitutes should exhibit optimal structural and mechanical features. This study aimed to test novel dermo‐epidermal skin substitutes based on collagen type I hydrogels, physically strengthened by two types of polymeric net‐like meshes. One mesh has already been used in clinical trials for treating inguinal hernia; the second one is new but consists of a FDA‐approved polymer. Both meshes were integrated into collagen type I hydrogels and dermo‐epidermal skin substitutes were generated. Skin substitutes were transplanted onto immuno‐incompetent rats and analyzed after distinct time periods. The skin substitutes homogeneously developed into a well‐stratified epidermis over the entire surface of the grafts. The epidermis deposited a continuous basement membrane and dermo‐epidermal junction, displayed a well‐defined basal cell layer, about 10 suprabasal strata and a stratum corneum. Additionally, the dermal component of the grafts was well vascularized. Copyright
Journal of Investigative Dermatology | 2014
Luca Pontiggia; Thomas Biedermann; Sophie Böttcher-Haberzeth; Carol Oliveira; Erik Braziulis; Agnieszka S. Klar; Claudia Meuli-Simmen; Martin Meuli; Ernst Reichmann
In our previous work, we showed that human sweat gland-derived epithelial cells represent an alternative source of keratinocytes to grow a near normal autologous epidermis. The role of subtypes of sweat gland cells in epidermal regeneration and maintenance remained unclear. In this study, we compare the regenerative potential of both secretory and absorptive sweat gland cell subpopulations. We demonstrate the superiority of secretory over absorptive cells in forming a new epidermis on two levels: first, the proliferative and colony-forming efficiencies in vitro are significantly higher for secretory cells (SCs), and second, SCs show a higher frequency of successful epidermis formation as well as an increase in the thickness of the formed epidermis in the in vitro and in vivo functional analyses using a 3D dermo-epidermal skin model. However, the ability of forming functional skin substitutes is not limited to SCs, which supports the hypothesis that multiple subtypes of sweat gland epithelial cells hold regenerative properties, while the existence and exact localization of a keratinocyte stem cell population in the human eccrine sweat gland remain elusive.
Journal of Immunology | 2010
Eliane Fischer; Sebastian Kobold; Sascha Kleber; Boris Kubuschok; Erik Braziulis; Alexander Knuth; Christoph Renner; Andreas Wadle
In search of novel markers for diagnosis, prognosis, and therapy of cancer, screening of rcDNA expression libraries with patient’s sera has been established as a valuable tool for identification of cancer-specific Ags. Interestingly, besides the expected humoral responses to annotated proteins, patients with cancer were frequently found to have serum Abs that bind to peptides without homology to known proteins. So far, the nature of these unconventional epitopes and their possible significance in tumor immunology have never been thoroughly investigated. In our study, we specifically analyzed humoral immune response toward such peptides in patients with pancreatic or breast cancer using yeast-displayed cDNA expression libraries derived from tumor tissue. A detailed analysis of the identified peptides revealed that they originated from translation of sequences outside annotated open reading frames and may derive from the use of alternative start codons or from DNA indel mutations. In several cases, the corresponding mRNA templates have a known association with cancer. In a final analysis, we were able to detect one of these tumor Ags in cancer tissue arrays by a selected Fab-Ab. We conclude that cryptic epitopes may elicit specific humoral immune responses in patients with cancer and thus play a role in immunologic surveillance. Due to the high prevalence of immune responses against some of the peptides, they may also be valuable markers for cancer diagnosis, prognosis, or therapy monitoring.
Tissue Engineering Part A | 2010
Irene Montaño; Clemens Schiestl; Jörg Schneider; Luca Pontiggia; Joachim Luginbühl; Thomas Biedermann; Sophie Böttcher-Haberzeth; Erik Braziulis; Martin Meuli; Ernst Reichmann
Tissue Engineering Part C-methods | 2012
Erik Braziulis; Mirco Diezi; Thomas Biedermann; Luca Pontiggia; Marlene Schmucki; Fabienne Hartmann-Fritsch; Joachim Luginbühl; Clemens Schiestl; Martin Meuli; Ernst Reichmann
Pediatric Surgery International | 2011
Erik Braziulis; Thomas Biedermann; Fabienne Hartmann-Fritsch; Clemens Schiestl; Luca Pontiggia; Sophie Böttcher-Haberzeth; Ernst Reichmann; Martin Meuli
Pediatric Surgery International | 2011
Clemens Schiestl; Thomas Biedermann; Erik Braziulis; Fabienne Hartmann-Fritsch; Sophie Böttcher-Haberzeth; Margarete Arras; Nikola Cesarovic; Flora Nicolls; Carsten Linti; Ernst Reichmann; Martin Meuli
Pediatric Surgery International | 2013
Fabienne Hartmann-Fritsch; Thomas Biedermann; Erik Braziulis; Martin Meuli; Ernst Reichmann